A novel crizotinib-resistant solvent-front mutation responsive to cabozantinib therapy in a patient with ROS1-rearranged lung cancer
Drilon, A., Somwar, R., Wagner, J. P., Vellore, N. A., Eide, C. A., Zabriskie, M. S., Arcila, M. E., Hechtman, J. F., Wang, L., Smith, R. S., Kris, M. G., Riely, G. J., Druker, B. J., O'Hare, T., LadaLanguage:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-15-2013
Date:
December, 2015
File:
PDF, 2.72 MB
english, 2015